Bicara Therapeutics Inc. Common Stock
NASDAQ:BCAXBiotechnology
Healthcare
$9.12 +0.00%
+$0.00 today
- Market cap
- $605.45M
- Beta
- -0.53
- P/E (TTM)
- -8.8
- EPS (TTM)
- -$2.59
52W Low $8.48High $24.25
Volume 0.84M
Average 0.54M
Price history
Bicara Therapeutics Inc. Common Stock SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-43.63%
Period high
$30.40
Period low
$7.93
Latest
$9.12
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| S-8 | Nov 10, 2026 | Nov 9, 2026 | |
| 8-K | Nov 9, 2026 | Nov 9, 2026 | |
| 10-Q | Nov 9, 2026 | Nov 9, 2026 | |
| SC 13G/A | Oct 7, 2026 | Oct 7, 2026 | |
| 4 | Sep 10, 2026 | Sep 10, 2026 | |
| 144 | Sep 8, 2026 | Sep 8, 2026 | |
| 144 | Sep 8, 2026 | Sep 8, 2026 | |
| 8-K | Aug 25, 2026 | Aug 25, 2026 | |
| 3 | Aug 14, 2026 | Aug 14, 2026 | |
| 4 | Aug 14, 2026 | Aug 14, 2026 | |
| SC 13G/A | Aug 13, 2026 | Aug 13, 2026 | |
| 4 | Aug 12, 2026 | Aug 12, 2026 | |
| 4 | Aug 12, 2026 | Aug 12, 2026 | |
| 4 | Aug 12, 2026 | Aug 12, 2026 | |
| 8-K | Aug 11, 2026 | Aug 11, 2026 |
Competitors
Who does Bicara Therapeutics Inc. Common Stock compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about BCAX's filings, answered from its disclosures.
What is the latest BCAX filing?
The latest filing shown is S-8 dated Nov 10, 2026.
How many recent filings does BCAX have?
Intrinsic Alpha currently shows 20 recent filings for BCAX.
Continue the stock analysis
Jump to another research area for this company.